PCN22 FIRST-LINE TREATMENT AND LIFETIME MEDICAL-CARE COSTS AMONG ELDERLY STAGE IIIB/IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH COMMONLY USED DOUBLET THERAPIES
Abstract
Authors
K Lang M Marciniak D Faries ME Stokes D Buesching C Earle J Treat S Babineaux D Thompson